| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.36 | - | - |
| Q3'25 | $1.19 | $1.23 | +3.2% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.6B | - | - |
| Q3'25 | - | $1.5B | - |
Market Data
EHC is currently trading at $121.74, giving Encompass Health Corporation a market cap of 12.20B and a P/E ratio of 20.0. Today's range spans $120.28–$122.32, with shares opening at $120.71 and moving up $1.43 (1.2%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 45/100.
Over the past year EHC has traded between $92.77 and $127.99 - the current price is +31.2% off the 52-week low and -4.9% from the high.
EHC carries a BUY signal on a 82/100 technical score, trades at $121.74 (in the upper portion of its 52-week range), and has neutral sentiment at 45/100. At 12.20B in the broader market market cap (P/E: 20.0), the name has scale without the index-anchor inertia of mega-cap peers - which means when the bullish momentum runs, the percentage move can be meaningfully larger. Annual range: $92.77–$127.99.
Earnings revision cycles in large-cap the broader market names tend to compound: when technicals confirm a BUY thesis (82/100) and news sentiment (45/100, neutral) supports the narrative, analyst upgrades follow price rather than lead it. At $121.74 (in the upper portion of its 52-week range), EHC's position within the $92.77–$127.99 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines
Log in to view your portfolios and holdings.
Create an account to set up email alerts.
Log in to see news for your portfolio holdings.